Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Crispr-Mediated Modulation of Egfr Signaling in Lung Cancer Publisher



M Tabibian MOBINA ; E Motevaseli ELAHE ; S Ghafourifard SOUDEH
Authors

Source: Cancer Treatment and Research Communications Published:2025


Abstract

Lung cancer is among the most common cancers and the leading source of cancer death. Inhibition of EGFR signaling by small-molecule tyrosine kinase inhibitors and monoclonal antibodies has provided new opportunities for treatment of this type of cancer. However, prognosis remained unfavorable due to the incidence of intrinsic or attained resistance. The advent of CRISPR/Cas9 technology has offered additional chances for cancer genome editing. This technology has been applied in the context of lung cancer research in order to minimize the effects of activating EGFR mutations. In the current manuscript, we address the application of CRISPR/Cas9 method in the modulation of EGFR signaling and its consequence in the treatment of lung cancer. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Crispr-Based Fluorescent Reporter (Cbfr) Assay for Sensitive, Specific, Inexpensive, and Visual Detection of a Specific Egfr Exon 19 Deletion in Nsclc, Molecular Biotechnology (2023)
2. Crispr Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential, Cell Proliferation (2025)
3. Prime Editing: The State-Of-The-Art of Genome Editing, Meta Gene (2020)
Experts (# of related papers)
View all Related Experts
Amir Ali Hamidieh (3)
Mohammad Vasei (2)
Other Related Docs
4. Crispr/Cas9 Revitalizes Adoptive T-Cell Therapy for Cancer Immunotherapy, Journal of Experimental and Clinical Cancer Research (2021)
5. Crispr-Cas9 in Basic and Translational Aspects of Cancer Therapy, BioImpacts (2024)
6. Clinical Applications of the Crispr/Cas9 Genome-Editing System: Delivery Options and Challenges in Precision Medicine, Genes and Diseases (2024)
7. Crispr/Cas and Artificial Intelligence to Improve Precision Medicine: Future Perspectives and Potential Limitations, Human Gene (2024)
8. Hpv-Driven Cancers: A Looming Threat and the Potential of Crispr/Cas9 for Targeted Therapy, Virology Journal (2025)
9. Targeting Mrna-Coding Genes in Prostate Cancer Using Crispr/Cas9 Technology With a Special Focus on Androgen Receptor Signaling, Cell Communication and Signaling (2024)
10. Optimizing Cancer Treatment: The Synergistic Potential of Car-T Cell Therapy and Crispr/Cas9, Frontiers in Immunology (2024)
11. Therapeutic Applications of Crispr/Cas9 System in Gene Therapy, Biotechnology Letters (2018)
12. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
13. Crispr-Cas9-Mediated Gene Therapy in Lung Cancer, Clinical and Translational Oncology (2023)
14. Functional Analysis of a Putative Her2-Associated Expressed Enhancer, Her2-Enhancer1, in Breast Cancer Cells, Scientific Reports (2023)
15. Crispr, Car-T, and Nk: Current Applications and Future Perspectives, Genes and Diseases (2024)
16. The Trend of Crispr-Based Technologies in Covid-19 Disease: Beyond Genome Editing, Molecular Biotechnology (2023)
17. Long Non-Coding Rna Snar Promotes Proliferation in Egfr Wild Type Non-Small Cell Lung Cancer Cells, International Journal of Molecular and Cellular Medicine (2021)
18. Implications of Crispr-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases, Current Problems in Cardiology (2023)
19. Crispr/Cas9-Engineered Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles: A New Approach to Overcoming Cell Therapy Limitations, Biomedicine and Pharmacotherapy (2022)
20. Harnessing Nanoparticles for the Efficient Delivery of the Crispr/Cas9 System, Nano Today (2020)